The short answer: An acquisition is financeable when the buyer's capital, the target's verifiable cash generation, the proposed price and the closing structure can satisfy a particular lender's mandate and repayment test. A signed LOI does not establish that. The right early question for an M&A broker is: What could cause a lender to fund less than the buyer expects, or decline the transaction altogether?
Two deals can have the same purchase price and radically different financing prospects. One target has reliable earnings, documented contracts, manageable debt and a team that stays after closing. The other depends on one departing founder, reports aggressive earnings add-backs and must replace key equipment. The buyer may see the same price tag; a lender sees different sources of repayment and different ways for the transaction to fail.
A review of 75 unsuccessful LOIs sourced through one transaction platform in 2025 found that non-financial diligence issues were the most common recorded reason for failure, at 25.3%. Discrepancies in EBITDA and quality of earnings accounted for 21.3%; direct financing constraints, 10.7% [1]. This is a sample of failed platform deals, not a failure rate for all LOIs. Its useful lesson is that lender readiness begins with the target's evidence, well before the final loan request.
What “financeable” means in practice
There is no universal yes or no. Lenders differ in sector, deal size, collateral, leverage, buyer profile, geography and tolerance for complex structures. A transaction that falls outside one bank's mandate may fit another capital provider; a strong buyer cannot, however, erase weak repayment capacity by changing lender names. Financeability is a comparison between a specific deal and a specific source of capital, under specific assumptions and documentation.
Can the combined business service its obligations while still operating?
How much real buyer and investor equity is available at closing?
What could reduce earnings, collateral value or the ability to close?
A broker does not need to make the lender's credit decision. The broker can identify the questions that will drive it, collect consistent evidence and avoid promising that the purchase price will be financed at a particular percentage. The buyer, seller, lender, accountants and counsel retain distinct responsibilities.
Seven tests for an acquisition financing screen
1. Reconcile reported earnings to sustainable cash generation
Start with historical income statements, tax filings when relevant, bank activity and a current management report. Understand how revenue turns into cash. EBITDA is a starting measure, not cash available for debt service. It excludes working-capital swings, capital expenditures, taxes and debt service itself. A lender may adjust the calculation for owner compensation, related-party transactions, one-time costs or expenses that will recur under new ownership.
Ask for every proposed add-back to be itemized, supported and labeled. If the seller says an expense disappears, will a replacement manager, lease, IT system or insurance policy create a new cost? If customer collections are slow, how much cash does growth consume? If a fleet or machine needs replacement, what annual reinvestment is required? A financial adviser may prepare a formal quality-of-earnings review; the broker's early role is to spot unsupported assumptions.
2. Test repayment with a slower first year
Translate projected cash generation into scheduled payments on existing and acquisition debt, including any seller note when payments begin. Consider taxes, maintenance investment, seasonal working capital and a reasonable operating reserve. Debt-service coverage is often expressed as cash available for debt service divided by required payments. The definitions and minimums vary by lender and transaction, so a broker should never present one ratio as a universal approval rule.
If annual cash available is $1.8 million and scheduled payments are $1.5 million, coverage is 1.20x. If cash available falls to $1.2 million, coverage falls to 0.80x. Those calculations describe a stress test, not a lender's policy or a credit decision.
Ask what happens if revenue is 10% lower, one major customer leaves, a supplier changes terms or integration costs exceed plan. The goal is to see whether the financing plan still leaves enough room for the business to operate. The acquisition should not require perfect execution every month merely to meet scheduled payments.
3. Separate purchase price from closing cash and total uses
A headline price can hide debt payoff, transaction fees, working-capital adjustments and opening liquidity. Reconcile enterprise value and equity value, clarify which liabilities are assumed or repaid, and show deferred seller consideration separately from cash funded on closing day. A seller note can reduce the immediate cash requirement but creates a future obligation; a rollover changes ownership and future upside. Neither automatically increases the target's operating cash flow.
For a more detailed sources-and-uses walkthrough, see our acquisition capital-stack article. This financing screen asks a different question: which parts of the agreed price and proposed structure can a capital provider actually support once it sees the evidence?
4. Inspect concentration, contracts and owner dependence
How much revenue depends on one customer, contract, distributor or referral partner? What happens to those relationships if the owner exits? Do major contracts require consent on a change of control? Are revenue streams recurring, cancellable or project-based? A lender may also examine industry cyclicality, regulatory exposure, insurance and the quality of the management team. These risks matter because debt is paid from future performance, not from the sale presentation.
Ask whether the seller will remain during transition, whether the operating leader is identified and whether the buyer has a credible plan for systems, employees, customers and suppliers. Contract and legal conclusions belong with counsel. The broker's useful contribution is to surface issues early and ensure the financing team sees the same facts as the buyer and seller.
5. Understand collateral, liens and the actual borrowing entity
Assets can help a lender manage loss risk, but their existence does not guarantee an acquisition loan or a lower rate. Identify who owns real estate, equipment, inventory and receivables, the existing liens, appraisal basis and whether the lender can take security over them. A seller may own property personally while the operating company only leases it. Some assets are essential to operations and difficult to liquidate; intellectual property can be valuable without being a straightforward source of secured lending capacity.
Compare the proposed debt with both cash flow and available collateral. Ask how liens will be discharged at closing and whether existing lenders must consent. The legal structure of an asset purchase, share purchase or holding-company acquisition may affect where debt sits and which cash flows and assets a lender can access. Tax and legal advisers should validate the structure.
6. Assess buyer equity and conditional capital
A lender commonly wants the buyer and its equity partners to absorb meaningful transaction risk. How much cash will the buyer contribute after keeping enough liquidity for the transition? Is outside equity funded, contractually committed or merely under discussion? If investor funding depends on due diligence, the LOI or a separate committee, note the condition and expected date. Do not confuse a proposed seller note with buyer equity.
Our companion guide, how to qualify an acquisition buyer before the LOI, provides a staged evidence checklist for this side of the transaction. Here the emphasis is whether the proposed debt amount can be supported by the target business and the final deal terms.
7. Match the deal to a lender mandate and timetable
Some lenders focus on recurring cash flow, others on assets, sponsor experience, sectors or deal sizes. A transaction may need different capital sources for purchase funding, working capital and longer-term growth. An early discussion should include a coherent overview of the buyer, target, price, sources and uses, repayment case, key risks, proposed security and closing schedule. Sending an incomplete teaser to many lenders can produce ambiguous “interest” without testing the actual financing question.
Document what the lender has seen and the stage of its response. General appetite, preliminary sizing, indicative terms, credit approval and funding are separate milestones. Terms may change after earnings verification, collateral review, committee approval and documentation. An originator needs a process that keeps the buyer and seller aligned with that reality.
Illustrative case: a $12 million deal and a weaker cash-flow result
Suppose an acquisition has a $12.0 million stated price and $1.2 million of fees, opening working capital and reserve, making total economic uses $13.2 million. The proposed sources are $3.0 million in buyer equity, $9.0 million in senior debt and a $1.2 million seller note. With the note deferred, closing cash needs of $12.0 million appear to match buyer equity plus senior debt. That is a mathematical reconciliation, not evidence a lender will advance $9.0 million.
Proposed economic sources, illustrative
Closing cash uses are $12.0 million only if the seller note validly defers $1.2 million of the stated consideration and the remaining uses are classified consistently. The agreement's actual price and adjustments control.
The buyer initially expects $1.8 million of annual cash available for debt service against $1.5 million of scheduled payments, or 1.20x illustrative coverage. During diligence, customer losses and recurring expenses reduce supportable cash to $1.2 million. Coverage becomes 0.80x. The lender may reduce the debt amount or change its terms. If the buyer's own equity remains at $3.0 million, any reduction in lender proceeds creates a new closing gap.
Potential responses are not interchangeable. Additional buyer equity addresses closing cash and lowers leverage. A seller note can move consideration into the future but adds payment obligations and may need subordination. An earnout can make part of the price contingent on later performance, but the seller must accept that risk and definitions must be negotiated. A lower price changes the deal economics. A different lender might have a different mandate, yet still needs a defensible repayment case. Counsel, accountants and the parties should work through the consequences before changing signed documents.
A lender-ready evidence map for the broker
| Question | Useful early evidence | What may change the answer |
|---|---|---|
| Are earnings repeatable? | Three years of statements, monthly interim results, add-back schedule | Revenue recognition, owner replacement costs, customer loss |
| Is cash available for debt? | Cash conversion, capex history, working-capital seasonality, debt schedule | Receivable delays, maintenance needs, existing covenants |
| Are assets usable as security? | Asset register, property ownership, liens and valuation basis | Prior charges, personal ownership, impaired assets |
| Will the business transfer? | Key contracts, management roles, owner transition plan | Change-of-control consent, key-person dependency |
| Can the buyer close? | Buyer equity evidence, investor conditions, sources and uses | Fundraising delays, committee approvals, price changes |
Do not circulate sensitive files without the company's authorization and an appropriate confidentiality process. A summary can be used to test initial fit, followed by deeper documents for suitable counterparties. Maintain one version of the sources-and-uses schedule and note every assumption. If multiple potential lenders ask different questions, keep the answers consistent and dated.
What to do when a lender says no or sizes lower
- Identify the binding objection. Was it repayment capacity, buyer equity, sector, customer concentration, collateral, structure, policy or missing information?
- Reconcile facts before changing the story. Correct an earnings error or missing document; do not treat an unsupported projection as a cure.
- Model the shortfall. Show closing cash, new debt service, seller proceeds and operating liquidity under the revised amount.
- Consider viable structures. Buyer equity, seller participation, contingent consideration, a revised price or a lender with a different mandate may help if the parties agree and repayment remains sound.
- Reset the timetable. If diligence or lender approval needs longer, discuss the LOI and purchase agreement with counsel before deadlines expire.
A decline is information. It does not prove no lender could ever finance the deal, nor does it justify shopping the same incomplete package indiscriminately. ALOS can help diagnose the funding gap, organize the evidence and identify lenders whose mandates fit the transaction. The lender owns underwriting, pricing and final approval.
Frequently asked questions
Can a strong buyer finance any profitable acquisition?
No. The target's cash generation, risk, purchase price, structure and available information still matter. A strong buyer may provide more equity or guarantees, but the final lender assessment remains transaction-specific.
Does a seller note make a deal bankable?
It can reduce cash paid at closing and align seller and buyer, but it also creates a later repayment claim. A senior lender may impose subordination or payment restrictions. The seller must understand the credit exposure and agree to the terms.
What is the difference between valuation and debt capacity?
Valuation is a negotiated assessment of ownership value, including prospects and strategic considerations. Debt capacity depends on a lender's view of sustainable repayment, risk, security and policy. A buyer can agree to a price higher than what debt alone can support and fund the difference with acceptable equity or another agreed structure.
When should the broker test financeability?
Before the buyer's financing assumptions harden into an LOI or purchase agreement, then again as diligence changes the facts. Early screening cannot replace formal underwriting, but it gives the parties time to correct an unrealistic plan.
Continue the acquisition financing series
First establish whether the buyer has a credible financing path before signing an LOI. Then use the acquisition capital-stack guide to compare equity, senior debt and deferred seller consideration. For a more general list of funding structures, see the financing options guide; the fit and rules of particular products depend on the deal's location and lender.
Bring us the transaction. Let’s test its financing path.
ALOS helps M&A originators organize the target’s financial evidence, map the closing gap and identify lenders whose mandates fit the buyer and business. With consent, we prepare the financing request and coordinate introductions. The lender makes the credit decision.
Each lender sets its own policy and decides whether and on what terms to fund. ALOS does not guarantee an approval or closing.Sources and methodology
The 2025 failed-LOI percentages describe 75 unsuccessful platform-sourced transactions and reasons assigned in that study. They are not percentages of all acquisitions or proof of causation beyond the study's classification. All dollar amounts, coverage calculations and alternative structures in the case study are hypothetical and educational, not offers or lender policy.
- Axial, Dead Deal Report: Unpacking 2025's Broken LOIs, January 2026, 75 unsuccessful platform-sourced transactions.
- BDC, How to conduct due diligence when buying a business, target financial, commercial and legal review.
- BDC, What are the steps to buying a business?, valuation, customer concentration, cash-flow predictability and financing sequence.
- IBBA, Common Business Buyer & Business Seller Questions, seller financing, earnouts and debt-service considerations; jurisdiction-specific examples on that page are not universal rules.
- Axial, Lower Middle Market 2H Outlook: M&A Advisors on Owner Sentiment, Deal Execution & Valuation Gaps, July 2026 survey of 79 dealmakers, directional respondent views.